Cleveland Clinic Taussig Cancer Institute
Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.
Clinical Implications of the HIMALAYA Study: Safety & Efficacy of Durvalumab & Tremelimumab Regimen in 1L Unresectable HCC
By
Cleveland Clinic Taussig Cancer Institute
FEATURING
Suneel Kamath
By
Cleveland Clinic Taussig Cancer Institute
FEATURING
Suneel Kamath
Login to view comments.
Click here to Login